As of 2024-12-11, the Fair Value of Homology Medicines Inc (FIXX) is -9.72 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 24.55 USD, the upside of Homology Medicines Inc is -139.57%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -103.92 | -128.69 | -95.76 | -5.01 | -112.96 | -89.27 |
| YoY growth | -86.97% | -23.84% | 25.59% | 94.77% | -2,154.71% | -429.03% |
| Market Cap (mil) | 32.69 |
| P/E | |
| Forward P/E |
| EPS | -1.94 |
| Avg earnings growth rate | -429.03% |
| TTM earnings | -112.95 |